E242- (CME) Past, Present, and Future: Muscarinic-Targeting Treatments for Schizophrenia
NEI Podcast
00:00
Innovations in Antipsychotic Treatment
This chapter explores a newly discussed medication for treating schizophrenia, focusing on its unique classification and absence of typical black box warnings. The speakers analyze its specific contraindications, dosage management for gastrointestinal issues, and necessary monitoring of liver function tests in patients. Additionally, the potential for weight neutrality and rational polypharmacy approaches in schizophrenia treatments is emphasized, showcasing the evolving landscape of psychiatric medication management.
Transcript
Play full episode
